Abstract
Anthrax is caused by exposure to Bacillus anthracis an aerobic, Gram-positive, spore-forming bacterial infection that most commonly infects herbivore mammals. Human infection occurs in those with close exposure to infected animal products. In fact, the first reported cases of anthrax, during the mid-1800s, were related to the textile and tanning industries in both England and Germany [1]. Infections were first documented in mill workers who were frequently exposed to imported animal fibers contaminated with B. anthracis spores.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Brachman P. Inhalational anthrax. Ann N Y Acad Sci. 1980;353:83–93.
Shafazand S, Doyle R, Ruoss S, Weinacker A, Raffin TA. Inhalational anthrax: epidemiology, diagnosis, and management. Chest. 1999;116:1369–76.
Inglesby TV, O’Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Gerberding J, Hauer J, Hughes J, McDade J, Osterholm MT, Parker G, Perl TM, Russell PK, Tonat K, Working Group on Civilian Biodefense. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA. 2002;287:2236–52.
Centers of Disease Control and Prevention. Inhalational anthrax associated with dried animal hides-Pennsylvania and New York City 2006. MMWR Morb Mortal Wkly Rep. 2006;55:280–2.
Centers for Disease Control and Prevention. Notice to readers: ongoing investigation of anthrax-Florida October 2001. MMWR Morb Mortal Wkly Rep. 2001;50:877.
Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. MMWR Morb Mortal Wkly Rep. 2001;50:941–8.
Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH. Pathology of inhalational anthrax 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci USA. 1993;90:2291–4.
Kyriacou DN, Stein AC, Yarnold PR, Courtney DM, Nelson RR, Noskin GA, Handler JA, Frerich RR. Clinical predictors of bioterrorism-related inhalational anthrax. Lancet. 2004;364:449–52.
Cote C, Welkos SL, Bozue J. Key aspects of the molecular and cellular basis of inhalational anthrax. Microbes Infect. 2011;13:1146–55.
Holty JE, Bravata DM, Liu H, Olshen RA, Mcdonald KM, Owens DK. Systematic review: a century of inhalational anthrax cases from 1900 to 2005. Ann Intern Med. 2003;144:270–80.
Wood BJ, Defranco B, Ripple M, Topiel M, Chiriboga C, Mani V, Barry K, Fowler D, Masur H, Borio L. Inhalational anthrax: radiologic and pathologic findings in two cases. Am J Roentgenol. 2003;181:1071–8.
Stern Eric J, Uhde Kristin B, Shadomy Sean V. Messonnier Nancy. Conference report on public health and clinical guidelines for anthrax. Emerg Infect Dis. 2008;14(4):e1. www.cdc.gov/eid/r/content/14/4/e1.htm.
International Consensus Conferences in Intensive Care Medicine. Noninvasive pressure ventilation in acute respiratory failure. Intensive Care Med. 2000;27:166–78.
Rana S, Jenad H, Gay PC, Buck CF, Hubmayr RD, Gajic O. Failure of non-invasive ventilation in patient with acute lung injury: observational cohort study. Crit Care. 2006;10(3):R79.
Keenan SP, Sinuff T, Cook DJ, Hill NS. Does noninvasive positive pressure ventilation in patients with acute lung injury: observational cohort study. Crit Care. 2004;32(12):2516–23.
Hui DS, Hall SD, Chan MT, Chow BK, Tsou JY, Joynt GM, et al. Noninvasive positive-pressure ventilation: an experimental model to assess air and particle dispersion. Chest. 2006;130(3):730–40.
Han F, Jiang II, Zheng JH, Gao ZC, He QY. Noninvasive positive pressure ventilation treatment for acute respiratory failure in SARS. Sleep Breath. 2004;8(2):97–106.
Mehta S, Hill Nicholas S. Noninvasive ventilation. Am J Respir Crit Care Med. 2001;163: 541–77.
Stefano N, Navalesi P, Conti G. Time of non-invasive ventilation. Intensive Care Med. 2006;32:361–70.
Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, Tapper M, Fisk TL, Zaki S, Popovic T, Meyer RF, Quinn CP, Harper SA, Fridkin SK, Sejvar JJ, Shepard CW, McConnell M, Guarner J, Shieh WJ, Malecki JM, Gerberding JL, Hughes JM, Perkins BA, Anthrax Bioterrorism Investigation Team. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis. 2001;7(6):933–44.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Wien
About this chapter
Cite this chapter
Mina, B., Abdelmessieh, P., Reed, M.J. (2014). Inhalational Anthrax and Bioterrorism: Key Recommendations for Acute Respiratory Failure. In: Esquinas, A. (eds) Noninvasive Ventilation in High-Risk Infections and Mass Casualty Events. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1496-4_19
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1496-4_19
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1495-7
Online ISBN: 978-3-7091-1496-4
eBook Packages: MedicineMedicine (R0)